Calcification and endothelialization of thrombi in acute stroke

Annals of Neurology

Volumn 64, Issue 3, 2008, Pages 344-347

  Almekhlafi, Mohammed A ^a   Hu, William Y ^a   Hill, Michael D ^a,b   Auer, Roland N ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CALCIFICATION; CEREBROVASCULAR ACCIDENT; CHEMICAL COMPOSITION; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; DISSOLUTION; ERYTHROCYTE; FEMALE; FIBRIN DEPOSITION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NEUTROPHIL; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; RECANALIZATION; STROKE PATIENT; THERAPY EFFECT; THROMBOGENESIS; THROMBUS;

EID: 54849442256     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.21404     Document Type: Article

References (15)

1. Molina CA, Saver JL. Extending reperfusion therapy for acute ischemic stroke: emerging pharmacological, mechanical, and imaging strategies. Stroke 2005;36:2311-2320.
2. Felten RP, Ogden NR, Peña C, et al. The Food and Drug Administration medical device review process: clearance of a clot retriever for use in ischemic stroke. Stroke 2005;36:404-406.
3. Khatri P, Neff J, Broderick JP, et al; IMS-I Investigators. Revascularization end points in stroke interventional trials: recanalization versus reperfusion in IMS-I. Stroke 2005;36:2400-2403.
4. Smith WS, Sung G, Starkman S, et al, MERCI Trial Investigators. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432-1438.
5. del Zoppo GJ, Poeck K, Pessin MS, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992;32:78-86.
6. Marder VJ, Chute DJ, Starkman S, et al. Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke. Stroke 2006;37:2086-2093.
7. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet 2000;355:1670-1674.
8. Gordon DL, Bendixen BH, Adams HP Jr, et al. Interphysician agreement in the diagnosis of subtypes of acute ischemic stroke: implications for clinical trials. The TOAST Investigators. Neurology 1993;43:1021-1027.
9. Higashida RT, Furlan AJ, Roberts H, et al; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology, Techno. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003;34:e109-e137.
10. Kirchhof K, Sikinger M, Welzel T, et al. [Does the result of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in rabbits depend on the erythrocyte- and fibrin-content of a thrombus?]. Rofo 2004;176:98-105.
11. Kumar R, Béguin S, Hemker HC. The effect of fibrin clots and clot-bound thrombin on the development of platelet procoagulant activity. Thromb Haemost 1995;74:962-968.
12. Niessen F, Hilger T, Hoehn M, Hossmann KA. Differences in clot preparation determine outcome of recombinant tissue plasminogen activator treatment in experimental thromboembolic stroke. Stroke 2003;34:2019-2024.
13. Halloran JI, Bekavac I. Unsuccessful tissue plasminogen activator treatment of acute stroke caused by a calcific embolus. J Neuroimaging 2004;14:385-387.
14. Oliveira-Filho J, Massaro AR, Yamamoto F, et al. Stroke as the first manifestation of calcific aortic stenosis. Cerebrovasc Dis 2000;10:413-416.
15. Mayer TE, Hamann GF, Brueckmann HJ. Treatment of basilar artery embolism with a mechanical extraction device: necessity of flow reversal. Stroke 2002;33:2232-2235.